| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |